Advertisement
Articles
Advertisement

Focus on Alliances 5/19/06

Fri, 05/19/2006 - 10:14am
COLLABORATIONS

Sirna Therapeutics and GlaxoSmithKline Begin Fight Against Asthma and RSV
Sirna Therapeutics Inc., San Francisco, as part of its multi-year respiratory disease collaboration with GlaxoSmithKline, Brentford, UK, began programs in asthma and respiratory syncytial virus (RSV), and plans to pursue therapeutics against chronic obstructive pulmonary disease.
Full Article

Cellectricon Partners with AstraZeneca
Cellectricon, Gothenburg, Sweden, will collaborate with AstraZeneca, London, UK, to develop a new microfluidic screening platform to advance the performance of cell-based ion channel assays in screening applications.
Full Article

Pieris Teams Up with GE Healthcare
Pieris Proteolab AG, Freising, Germany, and GE Healthcare, Chalfont St. Giles, UK, began a research collaboration to discover novel targeted in vivo diagnostic and medical imaging compounds.
Full Article

deCODE and Illumina Form Alliance
deCODE genetics, Reykjavik, Iceland, and Illumina Inc., San Diego, formed a strategic alliance to co-develop and commercialize DNA-based molecular diagnostic tests for the risk of heart attack, type 2 diabetes, and breast cancer.
Full Article

Multiple Partners Join for European Toxicity Project
Aureus Pharma, Paris, France, and ChemAxon Ltd., Budapest, Hungary, were awarded a European Eureka project along with sanofi-aventis, Paris, and Budapest University of Technology and Economics to build a new knowledge base related to hepatotoxicity.
Full Article

Oxford Genome and Medarex Sign Antibody Collaboration
Oxford Genome Sciences, Oxford, UK, and Medarex Inc., Princeton, N.J., began a strategic collaboration to discover and develop new human antibody therapeutics to treat a range of cancers, including colorectal cancer.
Full Article

Target Discovery Partners with Anderson Cancer Center
Target Discovery Inc., Palo Alto, Calif., will collaborate with researchers at The University of Texas M. D. Anderson Cancer Center, Houston, to develop a new generation of cancer diagnostic assays.
Full Article

Genzyme and Brookwood Join Forces on Peptide Delivery
Genzyme Pharmaceuticals, Cambrudge, Mass., and Brookwood Pharmaceuticals Inc., Birmingham, Ala., announced a broad collaboration to develop novel drug delivery solutions, focusing on peptide delivery.
Full Article

FivePrime and Boehringer Ingelheim Begin Arthritis Collaboration
Five Prime Therapeutics Inc., San Francisco, entered into a two-year collaborative research and license agreement with Boehringer Ingelheim, Ingelheim, Germany, to discover novel therapeutics to treat rheumatoid arthritis.
Full Article

AEterna Zentaris Collaborates with the University of Montreal
AEterna Zentaris Inc., Montreal, Canada, will partner with the University of Montreal on a three-year long preclinical research project studying the role of ghrelin in the development of obesity.
Full Article

RPI and Cleveland Clinic Enter Biomedical Research Collaboration
The Cleveland Clinic Lerner Research Institute, Ohio, and Rensselaer Polytechnic Institute (RPI), Troy, N.Y., will collaborate in nano-medicine, nano-bio materials, smart orthopedic implants, biomolecular imaging, biocomputation and bioinformatics, and drug delivery device development.
Full Article

Reveo and the University of Washington Join Forces for DNA Sequencing
Reveo Inc. Elmsford, N.Y., teamed up with the University of Washington, Bothell, to develop an invention for rapid sequencing of DNA using novel nano-scale electronic and photonic effects that bypass biochemical steps needed in conventional DNA sequencing methods.
Full Article

ACQUISITIONS

AstraZeneca to Purchase CAT
AstraZeneca, London, offered to buy Cambridge Antibody Technology (CAT), Cambridge, UK, which makes drugs from antibodies, for about US$1.3 billion. AstraZeneca already owns 19.2% of CAT from a research deal in 2004.
Full Article

Merck to Acquire GlycoFi
Merck & Co. Inc., Whitehouse Station, N.J., has agreed to acquire GlycoFi Inc., Lebanon, N.H., which will become a wholly-owned subsidiary of Merck, in an all-cash transaction valued at approximately $400 million.
Full Article

Millipore to Acquire Serologicals
Millipore Corp., Billerica, Mass., will acquire Serologicals Corp., Atlanta, for $31.55 per share in an all cash transaction, which will significantly strengthen Millipore's position in drug discovery, antibodies, cell biology reagents, and stem cell research.
Full Article

Sigma-Aldrich Acquires Iropharm
Sigma-Aldrich Corp., St. Louis, Mo., acquired Honeywell International's Iropharm unit, Arklow, Ireland, which will increase Sigma’s active pharmaceutical ingredient and intermediates manufacturing capacities.
Full Article

Biogen Idec Acquires Conforma Therapeutics
Biogen Idec, Cambridge, Mass., signed an agreement to acquire Conforma Therapeutics Corp., San Diego, for $150 million, and up to an additional $100 million upon achieving certain development milestones.
Full Article

Gentra Systems Acquired by QIAGEN
QIAGEN N.V., Venlo, The Netherlands, entered into an agreement to purchase all outstanding shares of Gentra Systems Inc., Minneapolis, Minn., which develops, manufactures, and supplies non-solid phase nucleic acid purification products.
Full Article

Lectus Acquires Assets of NeuroServe
Lectus Therapeutics Ltd., Bristol, UK, has acquired the assets including intellectual property, equipment, and expertise of NeuroServe Ltd, Cambridge, UK, an electrophysiology company that tests compounds on ion channels for pharmaceutical and biotech clients.
Full Article

MERGERS

Thermo Electron and Fisher Scientific to Merge
Thermo Electron Corp., Waltham, Mass., and Fisher Scientific International Inc., Hampton, N.H., approved a definitive agreement to merge, creating Thermo Fisher Scientific Inc., which is expected to have 2007 revenues of more than $9 billion.
Full Article

Alteon and HaptoGuard to Merge
Alteon Inc., Parsippany, N.J., and HaptoGuard Inc., New York, signed a definitive merger agreement whereby the two companies will combine operations in cardiovascular diseases, diabetes, and other inflammatory diseases.
Full Article

ADVENTRX Merges with SD Pharmaceuticals
ADVENTRX Pharmaceuticals Inc., San Diego, closed a merger with SD Pharmaceuticals Inc., Carlsbad, Calif., acquiring worldwide intellectual property rights to SD’s eight oncology and infectious disease therapeutic product candidates.
Full Article

Hawaii Biotech Merges with Avantogen
Hawaii Biotech Inc., Aiea, Hawaii, approved a merger between its vaccine division and Avantogen Ltd., Sydney, Australia. It will continue to be known as Hawaii Biotech Inc, and maintain the existing headquarters and laboratories in Oahu, Hawaii, and an office in California.
Full Article


Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading